EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

The Therapeutic Mechanism of Schisandrol A and Its Metabolites on Pulmonary Fibrosis Based on Plasma Metabonomics and Network Analysis

Xijier Qiaolongbatu iD, Wenjuan Zhao, Xucong Huang, Feng Qian, Xinyi Yang, Jiaqi Wu, Cui Ma, Han Qu iD, Li Wang, Guorong Fan, Zhenghua Wu

Drug Design, Development and Therapy · 2023

DOI: 10.2147/dddt.s391503 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Xijier Qiaolongbatu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, Pharm-X Center, School of Pharmacy, Shanghai Jiao Tong University,…. Hauptthemen laut MEDLINE: Transforming Growth Factor beta1, Pulmonary Fibrosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transforming Growth Factor beta1Pulmonary FibrosisMiceAnimalsTandem Mass SpectrometryChromatography, LiquidMetabolomicsBleomycinChromatography, High Pressure LiquidBiomarkersLignansCyclooctanesPolycyclic Compounds

Stichwörter der Autor:innen

mechanism of actionmetabonomicsnetwork analysispulmonary fibrosisschisandrol A

Substanzen

Transforming Growth Factor beta1BleomycinBiomarkersschisandrol ALignansCyclooctanesschizandrinPolycyclic Compounds

Autor:innen und Institutionen

  • Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, Pharm-X Center, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
  • Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.
  • School of Pharmacy, Chongqing Medical University, Chongqing, People's Republic of China.

ORCID-Profile: Xijier Qiaolongbatu, Han Qu

Zitieren

APA

Qiaolongbatu, X., Zhao, W., Huang, X., Qian, F., Yang, X., Wu, J., Ma, C., Qu, H., Wang, L., Fan, G., & Wu, Z. (2023). The Therapeutic Mechanism of Schisandrol A and Its Metabolites on Pulmonary Fibrosis Based on Plasma Metabonomics and Network Analysis. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s391503

Vancouver

Qiaolongbatu X, Zhao W, Huang X, Qian F, Yang X, Wu J, et al. The Therapeutic Mechanism of Schisandrol A and Its Metabolites on Pulmonary Fibrosis Based on Plasma Metabonomics and Network Analysis. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s391503

BibTeX
@article{Qiaolongbatu2023,
  author = {Qiaolongbatu, Xijier and Zhao, Wenjuan and Huang, Xucong and Qian, Feng and Yang, Xinyi and Wu, Jiaqi and Ma, Cui and Qu, Han and Wang, Li and Fan, Guorong and Wu, Zhenghua},
  title = {The Therapeutic Mechanism of Schisandrol A and Its Metabolites on Pulmonary Fibrosis Based on Plasma Metabonomics and Network Analysis},
  journal = {Drug Design, Development and Therapy},
  year = {2023},
  doi = {10.2147/dddt.s391503}
}
Kostenlos starten →